カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のボグリボース錠市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Voglibose Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
	◆商品コード：GIR23SM8016 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2023年9月 ◆ページ数：100 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のボグリボース錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のボグリボース錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ボグリボース錠の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ボグリボース錠市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・0.3mg、0.2mg、0.1mg

用途別セグメント
・病院、薬局、診療所、その他

主要な市場プレーヤー
・Takeda、Sun Pharmaceutical Industries Ltd.、Cisen Pharmaceutical Co., Ltd.、Zhejiang Jingxin Pharmaceutical Co., Ltd.、Nanjing Hicin Pharmaceutical Co., Ltd.、Beijing SL Pharmaceutical Co., Ltd.、JINRI Pharmaceutical (CHINA) Co., Ltd.、Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd.、Hainan Hualon Pharmaceutical Co., Ltd.、Chiatai Qingchunbao Pharmaceutical Co., Ltd.、Beijing UNION Pharmaceutical FACTORY、Shijiazhuang Huaxin Pharmaceutical Co., Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ボグリボース錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なボグリボース錠メーカーの企業概要、2019年～2022年までのボグリボース錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なボグリボース錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ボグリボース錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのボグリボース錠のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのボグリボース錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびボグリボース錠の産業チェーンを掲載しています。
・第14、15章では、ボグリボース錠の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ボグリボース錠の概要
– タイプ別分析（2018年vs2022年vs2029年）：0.3mg、0.2mg、0.1mg
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局、診療所、その他
– 世界のボグリボース錠市場規模・予測
– 世界のボグリボース錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Takeda、Sun Pharmaceutical Industries Ltd.、Cisen Pharmaceutical Co., Ltd.、Zhejiang Jingxin Pharmaceutical Co., Ltd.、Nanjing Hicin Pharmaceutical Co., Ltd.、Beijing SL Pharmaceutical Co., Ltd.、JINRI Pharmaceutical (CHINA) Co., Ltd.、Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd.、Hainan Hualon Pharmaceutical Co., Ltd.、Chiatai Qingchunbao Pharmaceutical Co., Ltd.、Beijing UNION Pharmaceutical FACTORY、Shijiazhuang Huaxin Pharmaceutical Co., Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：0.3mg、0.2mg、0.1mg
・用途別分析2018年-2029年：病院、薬局、診療所、その他
・ボグリボース錠の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ボグリボース錠のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ボグリボース錠のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ボグリボース錠の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ボグリボース錠の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Voglibose Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Voglibose Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.3mg
1.3.3 0.2mg
1.3.4 0.1mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Voglibose Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Clinic
1.4.5 Others
1.5 Global Voglibose Tablets Market Size & Forecast
1.5.1 Global Voglibose Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Voglibose Tablets Sales Quantity (2018-2029)
1.5.3 Global Voglibose Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Voglibose Tablets Product and Services
2.1.4 Takeda Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Recent Developments/Updates
2.2 Sun Pharmaceutical Industries Ltd.
2.2.1 Sun Pharmaceutical Industries Ltd. Details
2.2.2 Sun Pharmaceutical Industries Ltd. Major Business
2.2.3 Sun Pharmaceutical Industries Ltd. Voglibose Tablets Product and Services
2.2.4 Sun Pharmaceutical Industries Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.3 Cisen Pharmaceutical Co., Ltd.
2.3.1 Cisen Pharmaceutical Co., Ltd. Details
2.3.2 Cisen Pharmaceutical Co., Ltd. Major Business
2.3.3 Cisen Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.3.4 Cisen Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cisen Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Zhejiang Jingxin Pharmaceutical Co., Ltd.
2.4.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Details
2.4.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Major Business
2.4.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.4.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Nanjing Hicin Pharmaceutical Co., Ltd.
2.5.1 Nanjing Hicin Pharmaceutical Co., Ltd. Details
2.5.2 Nanjing Hicin Pharmaceutical Co., Ltd. Major Business
2.5.3 Nanjing Hicin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.5.4 Nanjing Hicin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nanjing Hicin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Beijing SL Pharmaceutical Co., Ltd.
2.6.1 Beijing SL Pharmaceutical Co., Ltd. Details
2.6.2 Beijing SL Pharmaceutical Co., Ltd. Major Business
2.6.3 Beijing SL Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.6.4 Beijing SL Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing SL Pharmaceutical Co., Ltd. Recent Developments/Updates
2.7 JINRI Pharmaceutical (CHINA) Co., Ltd.
2.7.1 JINRI Pharmaceutical (CHINA) Co., Ltd. Details
2.7.2 JINRI Pharmaceutical (CHINA) Co., Ltd. Major Business
2.7.3 JINRI Pharmaceutical (CHINA) Co., Ltd. Voglibose Tablets Product and Services
2.7.4 JINRI Pharmaceutical (CHINA) Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 JINRI Pharmaceutical (CHINA) Co., Ltd. Recent Developments/Updates
2.8 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd.
2.8.1 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Details
2.8.2 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Major Business
2.8.3 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Voglibose Tablets Product and Services
2.8.4 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Recent Developments/Updates
2.9 Hainan Hualon Pharmaceutical Co., Ltd.
2.9.1 Hainan Hualon Pharmaceutical Co., Ltd. Details
2.9.2 Hainan Hualon Pharmaceutical Co., Ltd. Major Business
2.9.3 Hainan Hualon Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.9.4 Hainan Hualon Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hainan Hualon Pharmaceutical Co., Ltd. Recent Developments/Updates
2.10 Chiatai Qingchunbao Pharmaceutical Co., Ltd.
2.10.1 Chiatai Qingchunbao Pharmaceutical Co., Ltd. Details
2.10.2 Chiatai Qingchunbao Pharmaceutical Co., Ltd. Major Business
2.10.3 Chiatai Qingchunbao Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.10.4 Chiatai Qingchunbao Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chiatai Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
2.11 Beijing UNION Pharmaceutical FACTORY
2.11.1 Beijing UNION Pharmaceutical FACTORY Details
2.11.2 Beijing UNION Pharmaceutical FACTORY Major Business
2.11.3 Beijing UNION Pharmaceutical FACTORY Voglibose Tablets Product and Services
2.11.4 Beijing UNION Pharmaceutical FACTORY Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing UNION Pharmaceutical FACTORY Recent Developments/Updates
2.12 Shijiazhuang Huaxin Pharmaceutical Co., Ltd.
2.12.1 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Details
2.12.2 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Major Business
2.12.3 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
2.12.4 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Voglibose Tablets by Manufacturer
3.1 Global Voglibose Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Voglibose Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Voglibose Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Voglibose Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Voglibose Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Voglibose Tablets Manufacturer Market Share in 2022
3.5 Voglibose Tablets Market: Overall Company Footprint Analysis
3.5.1 Voglibose Tablets Market: Region Footprint
3.5.2 Voglibose Tablets Market: Company Product Type Footprint
3.5.3 Voglibose Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Voglibose Tablets Market Size by Region
4.1.1 Global Voglibose Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Voglibose Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Voglibose Tablets Average Price by Region (2018-2029)
4.2 North America Voglibose Tablets Consumption Value (2018-2029)
4.3 Europe Voglibose Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Voglibose Tablets Consumption Value (2018-2029)
4.5 South America Voglibose Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Voglibose Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Voglibose Tablets Sales Quantity by Type (2018-2029)
5.2 Global Voglibose Tablets Consumption Value by Type (2018-2029)
5.3 Global Voglibose Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Voglibose Tablets Sales Quantity by Application (2018-2029)
6.2 Global Voglibose Tablets Consumption Value by Application (2018-2029)
6.3 Global Voglibose Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Voglibose Tablets Sales Quantity by Type (2018-2029)
7.2 North America Voglibose Tablets Sales Quantity by Application (2018-2029)
7.3 North America Voglibose Tablets Market Size by Country
7.3.1 North America Voglibose Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Voglibose Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Voglibose Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Voglibose Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Voglibose Tablets Market Size by Country
8.3.1 Europe Voglibose Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Voglibose Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Voglibose Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Voglibose Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Voglibose Tablets Market Size by Region
9.3.1 Asia-Pacific Voglibose Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Voglibose Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Voglibose Tablets Sales Quantity by Type (2018-2029)
10.2 South America Voglibose Tablets Sales Quantity by Application (2018-2029)
10.3 South America Voglibose Tablets Market Size by Country
10.3.1 South America Voglibose Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Voglibose Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Voglibose Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Voglibose Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Voglibose Tablets Market Size by Country
11.3.1 Middle East & Africa Voglibose Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Voglibose Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Voglibose Tablets Market Drivers
12.2 Voglibose Tablets Market Restraints
12.3 Voglibose Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Voglibose Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Voglibose Tablets
13.3 Voglibose Tablets Production Process
13.4 Voglibose Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Voglibose Tablets Typical Distributors
14.3 Voglibose Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Voglibose Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Voglibose Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Voglibose Tablets Product and Services
Table 6. Takeda Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Recent Developments/Updates
Table 8. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharmaceutical Industries Ltd. Major Business
Table 10. Sun Pharmaceutical Industries Ltd. Voglibose Tablets Product and Services
Table 11. Sun Pharmaceutical Industries Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 13. Cisen Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Cisen Pharmaceutical Co., Ltd. Major Business
Table 15. Cisen Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 16. Cisen Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cisen Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. Zhejiang Jingxin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Zhejiang Jingxin Pharmaceutical Co., Ltd. Major Business
Table 20. Zhejiang Jingxin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 21. Zhejiang Jingxin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 23. Nanjing Hicin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Nanjing Hicin Pharmaceutical Co., Ltd. Major Business
Table 25. Nanjing Hicin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 26. Nanjing Hicin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nanjing Hicin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Beijing SL Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Beijing SL Pharmaceutical Co., Ltd. Major Business
Table 30. Beijing SL Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 31. Beijing SL Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing SL Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 33. JINRI Pharmaceutical (CHINA) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. JINRI Pharmaceutical (CHINA) Co., Ltd. Major Business
Table 35. JINRI Pharmaceutical (CHINA) Co., Ltd. Voglibose Tablets Product and Services
Table 36. JINRI Pharmaceutical (CHINA) Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. JINRI Pharmaceutical (CHINA) Co., Ltd. Recent Developments/Updates
Table 38. Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Major Business
Table 40. Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Voglibose Tablets Product and Services
Table 41. Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co., Ltd. Recent Developments/Updates
Table 43. Hainan Hualon Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Hainan Hualon Pharmaceutical Co., Ltd. Major Business
Table 45. Hainan Hualon Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 46. Hainan Hualon Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hainan Hualon Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 48. Chiatai Qingchunbao Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Chiatai Qingchunbao Pharmaceutical Co., Ltd. Major Business
Table 50. Chiatai Qingchunbao Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 51. Chiatai Qingchunbao Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chiatai Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 53. Beijing UNION Pharmaceutical FACTORY Basic Information, Manufacturing Base and Competitors
Table 54. Beijing UNION Pharmaceutical FACTORY Major Business
Table 55. Beijing UNION Pharmaceutical FACTORY Voglibose Tablets Product and Services
Table 56. Beijing UNION Pharmaceutical FACTORY Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing UNION Pharmaceutical FACTORY Recent Developments/Updates
Table 58. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Major Business
Table 60. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Voglibose Tablets Product and Services
Table 61. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Voglibose Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Global Voglibose Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Voglibose Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Voglibose Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Voglibose Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Voglibose Tablets Production Site of Key Manufacturer
Table 68. Voglibose Tablets Market: Company Product Type Footprint
Table 69. Voglibose Tablets Market: Company Product Application Footprint
Table 70. Voglibose Tablets New Market Entrants and Barriers to Market Entry
Table 71. Voglibose Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Voglibose Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Voglibose Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Voglibose Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Voglibose Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Voglibose Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Voglibose Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Voglibose Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Voglibose Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Voglibose Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Voglibose Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Voglibose Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Voglibose Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Voglibose Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Voglibose Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Voglibose Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Voglibose Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Voglibose Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Voglibose Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Voglibose Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Voglibose Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Voglibose Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Voglibose Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Voglibose Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Voglibose Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Voglibose Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Voglibose Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Voglibose Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Voglibose Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Voglibose Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Voglibose Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Voglibose Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Voglibose Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Voglibose Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Voglibose Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Voglibose Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Voglibose Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Voglibose Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Voglibose Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Voglibose Tablets Raw Material
Table 131. Key Manufacturers of Voglibose Tablets Raw Materials
Table 132. Voglibose Tablets Typical Distributors
Table 133. Voglibose Tablets Typical Customers
List of Figures
Figure 1. Voglibose Tablets Picture
Figure 2. Global Voglibose Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Voglibose Tablets Consumption Value Market Share by Type in 2022
Figure 4. 0.3mg Examples
Figure 5. 0.2mg Examples
Figure 6. 0.1mg Examples
Figure 7. Global Voglibose Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Voglibose Tablets Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Retail Pharmacy Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Voglibose Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Voglibose Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Voglibose Tablets Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Voglibose Tablets Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Voglibose Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Voglibose Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Voglibose Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Voglibose Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Voglibose Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Voglibose Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Voglibose Tablets Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Voglibose Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Voglibose Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Voglibose Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Voglibose Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Voglibose Tablets Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Voglibose Tablets Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Voglibose Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Voglibose Tablets Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Voglibose Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Voglibose Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Voglibose Tablets Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Voglibose Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Voglibose Tablets Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Voglibose Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Voglibose Tablets Consumption Value Market Share by Region (2018-2029)
Figure 55. China Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Voglibose Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Voglibose Tablets Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Voglibose Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Voglibose Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Voglibose Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Voglibose Tablets Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Voglibose Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Voglibose Tablets Market Drivers
Figure 76. Voglibose Tablets Market Restraints
Figure 77. Voglibose Tablets Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Voglibose Tablets in 2022
Figure 80. Manufacturing Process Analysis of Voglibose Tablets
Figure 81. Voglibose Tablets Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のボグリボース錠市場2023年：企業・地域・タイプ・用途別分析(Global Voglibose Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のボグリボース錠市場2023年：企業・地域・タイプ・用途別分析

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp